Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

KBP Biosciences

Request full access

A multinational clinical stage biotechnology company developing innovative therapies for unmet medical needs

Princeton, United StatesFounded 2007Biotech & Life Sciences

About KBP Biosciences

KBP Biosciences is a globally recognized biotechnology company that focuses on the research and development of innovative therapies for unmet medical needs. The company operates in the pharmaceutical industry, serving patients suffering from hypertension, cardiorenal, and infectious diseases. KBP Biosciences uses a unique research and development platform to identify and develop products with significant differentiation. This platform is integrated with the company's compound library, allowing for efficient discovery and development of new drugs.

The company's business model is centered around the development of novel solutions for diseases and bringing these solutions from the laboratory to clinics worldwide. One of their recent achievements includes the completion of enrollment to its Phase 3 CLARION-CKD Study of Ocedurenone for uncontrolled hypertension in patients with advanced Chronic Kidney Disease (CKD). This shows the company's commitment to addressing critical health issues.

KBP Biosciences makes money by developing and selling these innovative therapies. The company's revenue comes from the sales of these drugs once they have been approved for use. The company also benefits from partnerships and collaborations with other entities in the pharmaceutical industry.

Source: Dealroom company data

At a glance

Status
Operational
Employees
44
Open positions
None listed
Dealroom signal
35.9/100
Industry
Health
Sub-industry
BioTechnology
Sector
Innovation Management, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing Jan 2018 $76M $304M Korea Investment Partners · SDIC Fund Management Company · Sangel Capital · Cowin Capital —
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

KBP Biosciences website traffic

Latest recorded traffic for KBP Biosciences is 670 monthly website visits, down 58.1% over the last three months. KBP Biosciences's team declined 2.2% over the past year.

Latest monthly visits670 3-month web change-58.1% 1-year team growth-2.2%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
BiohengA high-tech R&D innovation company Nanjing City, China Operational 18 $95M $320M
I360medicalI360medical partners with clinical experts and healthcare systems to identify, generate, and commercialize solutions that will transform patient care Dublin, Ireland Closed
GencoveDedicated to making genomic data more accessible and interpretable through molecular and software tools New York City, United States Operational
Hoba TherapeuticsDeveloper of neuropathic pain and CNS therapies. The company develops biopharmaceuticals for chronic pain and hearing loss Copenhagen, Denmark Operational
CotherixAffiliate of Actelion Pharmaceuticals Ltd, a biopharmaceutical company headquartered in Allschwil/Basel, Switzerland, that focuses on the discovery, development, and commercialization of innovative treatments to serve unmet medical needs San Francisco, United States Acquired
AMICOMEDThe first fully digital platform for blood pressure management combining innovative remote monitoring and lifestyle intervention San Francisco, United States Operational
Sealife PharmaSealife Pharma GmbH is an innovative drug development company Tulln, Austria Operational
MarinomedMarinomed is a biopharmaceutical company discovering and developing innovative anti-viral and immunological treatments Gemeinde Korneuburg, Austria Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

KBP Biosciences in the Princeton ecosystem

Live from Dealroom

The KBP Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A9 investors entered at this stage

  • SDIC Venture Capital
  • Advantech Capital
  • Korea Investment Partners
  • SDIC Fund Management Company
  • Sangel Capital
  • Cowin Capital
  • Bay City Capital
  • Ping An Ventures
  • Elite Capital
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States50%
🇨🇳 China38.9%
🇸🇬 Singapore11.1%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about KBP Biosciences on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See KBP Biosciences’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.